Navigation Links
BioScrip Reports Second Quarter 2014 Financial Results
Date:8/6/2014

ation or as a substitute or alternative to net income, operating income or any other performance measure derived in accordance with GAAP, or as a substitute or alternative to cash flow from operating activities or a measure of our liquidity. In addition, the Company's definitions of EBITDA, Adjusted EBITDA and Adjusted EPS may not be comparable to similarly titled non-GAAP financial measures reported by other companies. EBITDA represents net income before net interest expense, income tax expense, depreciation and amortization. Adjusted EBITDA, as defined by the Company, represents net income before net interest expense, loss on extinguishment of debt, income tax expense, depreciation and amortization, stock-based compensation expense, acquisition and integration expenses, restructuring-related expenses and investments in start-up operations. As part of restructuring, the Company may incur significant charges such as the write down of certain long−lived assets, temporary redundant expenses, retraining expenses, potential cash bonus payments and potential accelerated payments or terminated costs for certain of its contractual obligations. Adjusted EPS, as defined by the Company, represents earnings per basic and diluted share, excluding the same elements in calculating Adjusted EBITDA as well as the impact of acquisition-related intangible amortization. Management believes that these non-GAAP financial measures provide useful supplemental information regarding the performance of our business operations and facilitates comparisons to our historical operating results. For a full reconciliation of EBITDA, Adjusted EBITDA and Adjusted EPS to the most comparable GAAP financial measures, please see the attachments to this earnings release.

(Financial Tables Follow)

 

 Schedule 1BIOSCRIP, INC. AND SUBSIDIARIESCONSOLIDATED BALANCE SHEETS(in thousands, except for share amounts)June 30, 2014December 31, 2013(unaudited)ASSETSCurrent asse
'/>"/>

SOURCE BioScrip, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine technology :

1. Preliminary Financial Results, Quarterly Reports and Upcoming Conference Schedules - Research Report on Avanir, BioScrip, Chemed, Foundation Medicine, and Antares
2. BioScrip Reports Third Quarter 2013 Financial Results
3. BioScrip To Host Third Quarter 2013 Earnings Call
4. BioScrip Announces 2013 Investor Day
5. BioScrip Extends The Consent Payment Deadline And Expiration Date To July 30 For Its Previously Announced Tender Offer And Consent Solicitation
6. BioScrip Reports First Quarter 2013 Financial Results
7. BioScrip To Present At "NINE" Noble Financial Capital Markets Ninth Annual Equity Conference
8. Delcath Reports 2014 Second Quarter Results
9. InterMune Reports Second Quarter 2014 Financial Results and Business Highlights
10. Neurocrine Biosciences Reports Second Quarter 2014 Results
11. Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 2015 According to a new ... (Consumables, Instruments, Services), by Test Type (Indirect, Enzyme-based, Reactive ... by End Users - Global Forecast to 2020", published ... to reach $736.85 Million by 2020 from $452.36 Million ... Browse 71 market data Tables and 90 ...
(Date:5/22/2015)...  In a sweeping analysis assessing the current state ... researchers conclude that there remains considerable room for ... age groups, but especially for adolescents and young adults. ... treatment, underscoring the need to address barriers to care ... type 1 patients achieve optimal metabolic control. ...
(Date:5/21/2015)... 21, 2015  When Ryan Rendino first ... of his neck, he figured it was ... weeks off from weight lifting. ... A series of doctor ... to Michel Kliot, MD , a ...
Breaking Medicine Technology:Oxidative Stress Assays Market Worth $736.85 Million by 2020 2Oxidative Stress Assays Market Worth $736.85 Million by 2020 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 2Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 3Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 5Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4
(Date:5/26/2015)... (PRWEB) May 26, 2015 U.S. Food ... in the United States are extensive and can be ... firm that helps medical device companies comply with FDA ... medical device companies navigate FDA requirements. , 1. ... the United States can be a lengthy process depending ...
(Date:5/26/2015)... 26, 2015 Carl W. Berk, M.D. ... Center in Pinehurst, N.C. have launched a Balloon Sinuplasty ... about chronic sinusitis and the benefits of Balloon Sinuplasty. ... used to determine if someone is a good candidate ... and other factors that can contribute to chronic nasal ...
(Date:5/25/2015)... Garden City, NY (PRWEB) May 26, 2015 ... honors Laquanis Hooker as a 2015-2016 inductee into ... is recognized with this prestigious distinction for leadership in ... for professional women, boasting more than 700,000 members and ... to welcome Laquanis into this exceptional group of professional ...
(Date:5/25/2015)... York, New York (PRWEB) May 25, 2015 ... distributor of patented products, announces the Hidee-Hose, an undergarment ... or shorts. , "The Global Women's Hosiery industry forecasts ... Scott J. Cooper, CEO and Creative Director of ... the hosiery industry is steering ahead and is expected ...
(Date:5/25/2015)... 2015 Thousands of DePuy Pinnacle ... in the federal multidistrict litigation now underway in ... to a Motion filed on May 20th, plaintiffs’ ... Case Management Order pertaining to the Limited Authorization ... Motion seeks the adoption of a new form ...
Breaking Medicine News(10 mins):Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 2Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 3Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 4Health News:Pinehurst Surgical Sinus Center Launches Pinehurst Balloon Sinuplasty Website 2Health News:National Association of Professional Women Inducts Dr. Laquinas Hooked, D.D.S. of General Dentist, Into its VIP Professional Woman of the Year Circle 2Health News:For The Courtesy Of Women's Health And Looks - World Patent Marketing Presents A New Undergarment Patent 2Health News:For The Courtesy Of Women's Health And Looks - World Patent Marketing Presents A New Undergarment Patent 3Health News:Federal DePuy Pinnacle Hip Lawsuits Move Forward, as Plaintiffs Seek to Modify Order Pertaining to Health Authorizations 2Health News:Federal DePuy Pinnacle Hip Lawsuits Move Forward, as Plaintiffs Seek to Modify Order Pertaining to Health Authorizations 3
... occur on MySpace and Facebook, study finds , , FRIDAY, ... sites such as MySpace and Facebook have been singled ... most of the unwanted solicitation actually happens in chat ... , Even there, only 15 percent of children experience ...
... drugs (NSAIDs) are used to treat arthritis, which affects ... both prescription and over-the-counter (OTC) forms and are one ... Because of their widespread availability, patients may take both ... pain relief or because they are unaware that they ...
... with locally advanced laryngopharyngeal cancers who receive radical ... 12 months following treatment when compared with patients ... voice restoration, according to a study in the ... Radiation Oncology*Biology*Physics, the official journal of the American ...
... Aurora Health, Care and HealthEOS announced today that they have reached ... ... 1 As a result of the settlement,agreement, WPS customers that ... physicians and facilities through the end of,2008. The services provided to ...
... Smokers have a two-fold increased risk of developing ... cancers (CRC), according to a study published in Gastroenterology, ... Institute. , The results from this meta-analysis ... never smokers, 1.82 for ever versus never smokers and ...
... 1, 2008) - Amgen (NASDAQ: AMGN) and Wyeth Pharmaceuticals, ... from a retrospective analysis, which demonstrated that ENBREL reduced ... with moderate to severe plaque psoriasis following 12 weeks ... 10 times greater in the ENBREL treated group compared ...
Cached Medicine News:Health News:Social Networking Sites Safer Than IM or Chat Rooms 2Health News:Social Networking Sites Safer Than IM or Chat Rooms 3Health News:Taking more than 1 anti-inflammatory drug may lead to complications 2Health News:Larynx preservation preferred over total laryngectomy 2Health News:Wisconsin Physicians Service Insurance Corporation, Aurora Health Care and HealthEOS Announce Settlement Agreement 2Health News:Smoking can double risk of colorectal polyps 2Health News:New findings show Enbrel significantly reduced levels of C-reactive protein 2Health News:New findings show Enbrel significantly reduced levels of C-reactive protein 3Health News:New findings show Enbrel significantly reduced levels of C-reactive protein 4Health News:New findings show Enbrel significantly reduced levels of C-reactive protein 5
Vaulted shank with guard....
... are individually adjusted for perfect focus where ... on paper. This, along with Keeler's wide ... that whatever the patient's pupil size, you ... of view. Lithium-ion technology provides a longer ...
... Beta 200 ophthalmoscope, the ... direct ophthalmoscope. Heine's aspherical ... #4,963,014) along with innovative ... make the Beta 200 ...
... Heine Beta 200S is the ... a combination of patented aspherical ... a range of corrective lenses ... in single diopter steps. A ...
Medicine Products: